GlassScriptPhysician profile
Kenneth A Thompson
NPI 1669489100
$476.36
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $58.59 · 2022: $10.32 · 2023: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $149.75 | 2019-2020 | |
| Daiichi Sankyo INC. | $43.93 | 2020-2023 | Injectafer |
| Amgen INC. | $27.55 | 2019 | |
| Shire North American Group INC | $25.56 | 2019 | |
| Roche Diagnostics Corporation | $24.47 | 2019 | |
| Exeltis, USA INC. | $22.72 | 2023 | Slynd |
| Dexcom, INC. | $20.05 | 2023 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $19.40 | 2023 | Myfembree |
| Exact Sciences Corporation | $16.16 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $15.71 | 2019 | |
| Novo Nordisk INC | $14.15 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.49 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.28 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.26 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.81 | 2019 | |
| Avion Pharmaceuticals | $11.66 | 2019 | |
| Allergan, INC. | $10.87 | 2019 | |
| Aspira Women'S Health INC | $10.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.